Latest market price
26.96
+0.38+1.43%
Earnings
Up 1.4% — Reported earnings — EPS missed by 8%, revenue beat by 3%.
High confidence
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | -1.76 | Insider Own | 23.06% | Shs Outstand | 38.38M | Perf Week | -0.26% |
| Market Cap | 1.03B | Forward P/E | — | EPS next Y | -1.61 | Insider Trans | -5.75% | Shs Float | 25.57M | Perf Month | 13.80% |
| Enterprise Value | 927.67M | PEG | — | EPS next Q | -0.50 | Short Float | 8.43% | Perf Quarter | 45.57% | ||
| Income | -66.00M | P/S | 10.14 | EPS this Y | — | Short Ratio | 5.42 | Perf Half Y | 33.00% | ||
| Sales | 102.00M | P/B | 8.08 | EPS next Y | — | ROA | -39.67% | Short Interest | 2.16M | Perf YTD | 22.94% |
| Book/sh | 3.34 | P/C | 8.02 | EPS next 5Y | — | ROE | -44.85% | 52W High | 28.19 -4.36% | Perf Year | 138.16% |
| Cash/sh | 3.36 | P/FCF | — | EPS past 3/5Y | — | ROIC | -46.54% | 52W Low | 10.85 148.48% | Perf 3Y | — |
| Dividend Est. | — | EV/EBITDA | — | Sales past 3/5Y | 50.71% — | Gross Margin | 88.90% | Volatility | 3.92% 5.29% | Perf 5Y | — |
| Dividend TTM | — | EV/Sales | 9.09 | EPS Y/Y TTM | — | Oper. Margin | -68.62% | ATR (14) | 1.26 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 8.79 | Sales Y/Y TTM | 32.47% | Profit Margin | -64.73% | RSI (14) | 56.00 | Recom | 2.00 |
| Dividend Gr. 3/5Y | — | Current Ratio | 9.18 | EPS Q/Q | -34.21% | SMA20 | 3.05% | Beta | 1.19 | Target Price | 27.50 |
| Payout | 0.00% | Debt/Eq | 0.17 | Sales Q/Q | 33.33% | SMA50 | 7.93% | Rel Volume | 2.08 | Prev Close | 26.58 |
| Employees | 327 | LT Debt/Eq | 0.16 | Earnings | Nov 03 | SMA200 | 29.62% | Avg Volume | 439.05K | Price | 26.96 |
| IPO Date | Oct 11, 2024 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -8.24% 3.01% | Net Debt/EBITDA | — | Volume | 912,649 | Change | 1.43% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-03-26 | Reiterated | Raymond James | $29 | |
| Aug-11-26 | Reiterated | Canaccord Genuity | Buy | $25 → $26 |
| May-12-26 | Reiterated | Canaccord Genuity | Buy | $30 → $25 |
| Dec-15-25 | Reiterated | BTIG | Buy | $30 |
| Nov-05-24 | Reiterated | Canaccord Genuity | $30 |
Latest News· Times ET
Nov-02-26
Nov-02-2607:00AM
Oct-28-26
Oct-28-2604:05PM
Oct-25-26
Oct-20-26
Oct-20-2604:05PM
Oct-14-26
Oct-14-2607:22PM
Oct-02-26
Sep-30-26
Sep-30-2607:00AM
Sep-11-26
Sep-02-26
Aug-27-26
Aug-27-2603:39AM
Aug-18-26
Aug-18-2604:26AM
Aug-12-26
Aug-12-2611:05AM
Aug-11-26
05:28AM
CeriBell, Inc. (CBLL) Q2 2026 Earnings Call Transcriptseekingalpha.com
Aug-10-26
Company
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | |
|---|---|---|---|---|---|---|
| Total Revenue | 102 | 89 | 65 | 45 | — | |
| Cost of Goods Sold Incl. D&A | 11 | 11 | 9 | 7 | — | |
| Gross Profit | 91 | 78 | 57 | 38 | — | |
| Selling, General and Administrative Excl. Other | 138 | 118 | 83 | 59 | — | |
| Research and Development | 23 | 19 | 14 | 9 | — | |
| Other Operating Expense | 0 | 0 | -1 | 0 | — | |
| Operating Income | -71 | -58 | -40 | -30 | — | |
| Interest Expense | 0 | 2 | 2 | 2 | — | |
| Unusual Expense | — | — | — | — | — | |
| Non-Operating Income (Expense) | 6 | 7 | 1 | 3 | — | |
| Net Income Before Taxes | -66 | -53 | -40 | -29 | — | |
| Income Taxes | 0 | 0 | 0 | 0 | — | |
| Consolidated Net Income | -66 | -53 | -40 | -29 | — | |
| Net Income From Continuing Operations | -66 | -53 | -40 | -29 | — | |
| Net Income | -66 | -53 | -40 | -29 | — | |
| EPS (Recurring) | -1.76 | -1.46 | -1.13 | -1.26 | — | |
| EPS (Basic, Before Extraordinaries) | -1.76 | -1.46 | -1.13 | -1.26 | — | |
| EPS (Diluted) | -1.76 | -1.46 | -1.13 | -1.26 | — | |
| EBITDA | -64 | -50 | -37 | -27 | — | |
| Other After Tax Adjustments | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | |
| Price To Sales Ratio | 10.04 | 9.12 | 14.33 | — | — | |
| Gross Margin | 89.22 | 87.64 | 87.69 | 84.44 | — | |
| Operating Margin | -69.61 | -65.17 | -61.54 | -66.67 | — | |
| Net Margin | -64.71 | -59.55 | -61.54 | -64.44 | — | |
| Shares Outstanding | 38 | 37 | 36 | 23 | — | |
| Market Capitalization | 1,024 | 811 | 932 | — | — | |
| Operating Lease Expense | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Woo Raymond | Chief Technology Officer | Oct 01 '26 | Option Exercise | 3.65 | 4,887 | 17,862 | 208,005 | Oct 02 |
| Woo Raymond | Chief Technology Officer | Oct 01 '26 | Sale | 24.38 | 4,887 | 119,145 | 203,118 | Oct 02 |
| Blumberg Scott | Chief Financial Officer | Sep 15 '26 | Option Exercise | 9.41 | 846 | 7,961 | 147,446 | Sep 17 |
| Blumberg Scott | Chief Financial Officer | Sep 15 '26 | Sale | 25.00 | 846 | 21,150 | 146,600 | Sep 17 |
| Chao Xingjuan | President and CEO | Sep 15 '26 | Sale | 25.03 | 20,846 | 521,775 | 746,345 | Sep 17 |
| Woo Raymond | Chief Technology Officer | Sep 08 '26 | Sale | 24.33 | 4,887 | 118,901 | 203,118 | Sep 10 |
| Woo Raymond | Chief Technology Officer | Sep 08 '26 | Option Exercise | 2.76 | 13,276 | 36,653 | 208,005 | Sep 10 |
| Foehr David | Senior VP, Finance and PAO | Sep 08 '26 | Option Exercise | 4.70 | 7,500 | 35,250 | 41,644 | Sep 10 |
| Foehr David | Senior VP, Finance and PAO | Sep 08 '26 | Sale | 24.25 | 9,255 | 224,451 | 34,144 | Sep 10 |
| Chao Xingjuan | President and CEO | Sep 02 '26 | Sale | 24.61 | 39,540 | 973,079 | 767,191 | Sep 04 |
| Blumberg Scott | Chief Financial Officer | Sep 02 '26 | Option Exercise | 9.41 | 652 | 6,135 | 147,252 | Sep 04 |
| Blumberg Scott | Chief Financial Officer | Sep 02 '26 | Sale | 25.00 | 652 | 16,300 | 146,600 | Sep 04 |
| Chao Xingjuan | President and CEO | Sep 02 '26 | Option Exercise | 4.70 | 25,000 | 117,500 | 806,731 | Sep 04 |
| Foehr David | Senior VP, Finance and PAO | Aug 24 '26 | Sale | 23.95 | 859 | 20,573 | 35,899 | Aug 25 |
| Chao Xingjuan | President and CEO | Aug 21 '26 | Sale | 24.02 | 6,068 | 145,753 | 781,731 | Aug 25 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.